Nasal-associated lymphoid tissue
Nasal-associated lymphoid tissue (NALT) is a component of the mucosa-associated lymphoid tissue (MALT) that is found in the nasal cavity. It plays a crucial role in the immune system by serving as a site for the induction of immune responses to inhaled antigens. NALT is considered to be the nasal equivalent of the tonsils and adenoids found in the oropharynx and nasopharynx, respectively.
Structure[edit]
NALT is located in the upper part of the nasal cavity, specifically in the area of the nasal septum and the lateral wall of the nasal passages. It consists of organized lymphoid follicles that contain B cells, T cells, dendritic cells, and macrophages. These follicles are similar in structure to those found in the Peyer's patches of the small intestine.
The lymphoid follicles of NALT are covered by a specialized epithelium known as the follicle-associated epithelium (FAE), which contains microfold cells (M cells). These M cells are responsible for the uptake and transport of antigens from the nasal cavity to the underlying immune cells, facilitating the initiation of immune responses.
Function[edit]
NALT functions as a critical site for the induction of mucosal immunity. It is involved in the generation of IgA-producing plasma cells, which are essential for the production of secretory IgA (sIgA) antibodies. These antibodies play a key role in neutralizing pathogens and preventing their entry into the body through the nasal mucosa.
In addition to its role in humoral immunity, NALT is also involved in the activation of cell-mediated immunity. It provides a site for the activation and proliferation of T lymphocytes, which can then migrate to other parts of the body to exert their immune functions.
Development[edit]
NALT develops during the early stages of life and is fully functional in young individuals. It undergoes changes with age, and its activity may decline in older individuals. The development and maintenance of NALT are influenced by various factors, including genetic factors and environmental exposures.
Clinical Significance[edit]
NALT is an important target for mucosal vaccination strategies. Vaccines administered intranasally can stimulate immune responses in NALT, leading to the production of both local and systemic immunity. This approach is particularly useful for protecting against respiratory pathogens such as influenza virus and SARS-CoV-2.
Research[edit]
Research on NALT has provided insights into the mechanisms of mucosal immunity and the development of novel vaccination strategies. Studies have shown that NALT can be a site for the induction of tolerance to inhaled antigens, which has implications for the treatment of allergic rhinitis and other allergic diseases.
